A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.

J Voortman; EF Smit; BC Kuenen; HM Pinedo; C van Groeningen; AJ van den Eertwegh; D Brouwer; H van de Velde; G Giaccone

A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.

J Voortman
, EF Smit
, BC Kuenen
, HM Pinedo
, C van Groeningen
, AJ van den Eertwegh
, D Brouwer
, H van de Velde
, G Giaccone

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	160S-160S
Journal	Journal of clinical oncology
Volume	23
Issue number	16
Publication status	Published - 1 Jun 2005

Cite this

Voortman, J., Smit, EF., Kuenen, BC., Pinedo, HM., van Groeningen, C., van den Eertwegh, AJ., Brouwer, D., van de Velde, H., & Giaccone, G. (2005). A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study. Journal of clinical oncology, 23(16), 160S-160S.

@article{1149804ea7544f65bc355d5959fe88eb,

title = "A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.",

author = "J Voortman and EF Smit and BC Kuenen and HM Pinedo and \{van Groeningen\}, C and \{van den Eertwegh\}, AJ and D Brouwer and \{van de Velde\}, H and G Giaccone",

year = "2005",

month = jun,

day = "1",

language = "English",

volume = "23",

pages = "160S--160S",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

}

Voortman, J, Smit, EF, Kuenen, BC, Pinedo, HM, van Groeningen, C, van den Eertwegh, AJ, Brouwer, D, van de Velde, H & Giaccone, G 2005, 'A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.', Journal of clinical oncology, vol. 23, no. 16, pp. 160S-160S.

A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study. / Voortman, J; Smit, EF; Kuenen, BC et al.
In: Journal of clinical oncology, Vol. 23, No. 16, 01.06.2005, p. 160S-160S.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.

AU - Voortman, J

AU - Smit, EF

AU - Kuenen, BC

AU - Pinedo, HM

AU - van Groeningen, C

AU - van den Eertwegh, AJ

AU - Brouwer, D

AU - van de Velde, H

AU - Giaccone, G

PY - 2005/6/1

Y1 - 2005/6/1

M3 - Meeting Abstract

SN - 0732-183X

VL - 23

SP - 160S-160S

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 16

ER -

Voortman J, Smit EF, Kuenen BC, Pinedo HM, van Groeningen C, van den Eertwegh AJ et al. A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study. Journal of clinical oncology. 2005 Jun 1;23(16):160S-160S.